SignatureFD’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-98
Closed -$2.71K 3178
2023
Q4
$2.71K Buy
98
+73
+292% +$4.45K ﹤0.01% 2688
2023
Q3
$1.54K Hold
25
﹤0.01% 2841
2023
Q2
$1.63K Buy
25
+9
+56% +$658 ﹤0.01% 2867
2023
Q1
$1K Sell
16
-6
-27% -$685 ﹤0.01% 2994
2022
Q4
$3.02K Buy
22
+7
+47% +$986 ﹤0.01% 2662
2022
Q3
$2K Buy
+15
New +$1.7K ﹤0.01% 2736
2022
Q2
Sell
-13
Closed -$1K 3124
2022
Q1
$1K Hold
13
﹤0.01% 2951
2021
Q4
$3K Sell
13
-6
-32% -$1.42K ﹤0.01% 2558
2021
Q3
$5K Sell
19
-96
-83% -$27.4K ﹤0.01% 2329
2021
Q2
$47K Buy
115
+4
+4% +$1.58K ﹤0.01% 1295
2021
Q1
$43K Buy
111
+1
+0.9% +$492 ﹤0.01% 1235
2020
Q4
$62K Buy
110
+101
+1,122% +$64K ﹤0.01% 982
2020
Q3
$7K Buy
9
+2
+29% +$1.56K ﹤0.01% 1759
2020
Q2
$5K Buy
7
+6
+600% +$4.52K ﹤0.01% 1776
2020
Q1
$1K Sell
1
-3
-75% -$2.92K ﹤0.01% 2072
2019
Q4
$4K Buy
+4
New +$4.35K ﹤0.01% 1674
2018
Q1
Sell
-128
Closed -$294K 1738
2017
Q4
$294K Buy
+128
New +$260K 0.04% 238

Other funds holding BLUE

SignatureFD's BLUE Position: Q1 2024 in Review

SignatureFD sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 98 shares — an estimated $2.71K sold.

SignatureFD first reported a position in BLUE in Q4 2017 and held it in 17 quarters. The position peaked at $294K in Q4 2017. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • SignatureFD reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • SignatureFD sold 98 bluebird bio shares in Q1 2024, an estimated $2.71K.
  • SignatureFD first reported a position in bluebird bio in Q4 2017 and held it in 17 quarters.
  • SignatureFD's bluebird bio position peaked at $294K in Q4 2017.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on SignatureFD's 13F filing for Q1 2024, filed 3 May 2024.